US2020002212A1PendingUtilityA1

Method of producing glass vials

Assignee: SCHOTT AGPriority: Jul 17, 2013Filed: Sep 9, 2019Published: Jan 2, 2020
Est. expiryJul 17, 2033(~6.9 yrs left)· nominal 20-yr term from priority
C03B 23/092C03B 23/11C03B 21/06C03B 23/049B65D 1/09C03C 21/002C03C 4/20
66
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method for producing glass vials, in particular pharmaceutical vials or pharmaceutical ampoules, from a glass tube is provided, the method including the following steps: (a) rotating the glass tube about a longitudinal axis thereof; (b) locally heating the glass tube from one side by means of at least one burner to at least the softening temperature of the glass; (c) reducing the diameter by pressing at least one forming body laterally against the heated region; and (d) separating the glass tube by means of a burner. A glass vial produced in such a way releases a reduced amount of alkali in accordance with ISO 4802 and has a decreased delamination tendency. Furthermore, in the hot-formed peripheral region, the alkali content is only slightly reduced when compared with the alkali content in the glass interior.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A glass vial comprising a closed bottom and an open bottleneck, the glass vial consisting of a neutral glass configured as a borosilicate glass, wherein an alkali content within a heat-deformed region close to a surface of the glass vial is reduced by 30% at most when compared to an alkali content within an glass interior of the glass vial given by a composition of the borosilicate glass. 
     
     
         2 . The glass vial of  claim 1 , wherein the alkali content within the heat-deformed region close to the surface is reduced by 20% at most when compared to the alkali content within the glass interior. 
     
     
         3 . The glass vial of  claim 1 , wherein the alkali content within the heat-deformed region close to the surface is reduced by 10% at most when compared to the alkali content within the glass interior. 
     
     
         4 . The glass vial of  claim 1 , comprising a sodium release according to ISO 4802-2 that is smaller than 0.5 μg/cm 2 . 
     
     
         5 . The glass vial of  claim 4 , wherein the sodium release according to ISO 4802-2 is smaller than 0.25 μg/cm 2 . 
     
     
         6 . A glass vial comprising a closed bottom, an open bottleneck, and a sodium release according to ISO 4802-2 that is smaller than 0.5 μg/cm 2 . 
     
     
         7 . The glass vial of  claim 6 , wherein the glass vial is a pharmaceutical vial or a pharmaceutical ampoule. 
     
     
         8 . The glass vial of  claim 6 , wherein the sodium release according to ISO 4802-2 is smaller than 0.25 μg/cm 2 .

Join the waitlist — get patent alerts

Track US2020002212A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.